Sarcoma Research
Sarcoma Research
Research into sarcoma at Penn State Cancer Institute is conducted by a dedicated sarcoma team. See current clinical trials and members of that team here.
Clinical Trials
Blood and Bone Marrow Sampling for Tissue Banking
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens including Rare Pediatric Tumors.
Protocol for the Enrollment on the Official COG Registry, the Childhood Cancer Research Network (CCRN)
A Children's Oncology Group Protocol for Collecting and Banking Ewing Sarcoma Specimens
Umbrella Long-term Follow-up Protocol
A COG Protocol for Collecting and Banking Osteosarcoma Specimens
Renal Tumor Classification, Biology, and Banking Study
A COG Soft Tissue Sarcoma Biology and Banking Protocol
A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating with Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864, IND# 122782) in Patients with Intermediate Risk (IR) Rhabdomyosarcoma (RMS)
The Collection of Blood, Tissue and Phenotypic Data in Patients Diagnosed with Skin Cancers and Subsequent Metastases for Inclusion in a Repository and Use in Outcome Studies
Molecular-Guided Therapy for the Treatment of Patients with Relapsed and Refractory Childhood Cancers
A Phase II Study of Pazopanib (GW786034, NSC# 737754) in Children, Adolescents and Young Adults with Refractory Solid Tumors
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib
Randomized Phase III Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
A Phase I/II, Multicenter, Open-Label, Dose Escalation Study of the Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Patients with Previously Treated Solid Tumors
The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
Phase II Study of Denosumab (NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma
Protocol for a Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation
Protocol for a Research Database for Hematopoietic Cell Transplantation, other Cellular Therapies and Marrow Toxic Injuries.
Disease Team Members
| First Name | Last Name | Title | Role | ||
|---|---|---|---|---|---|
| Joseph | Drabick | MD, FACP | View Profile | ||
| Edward | Fox | MD | View Profile | ||
| Harold | Harvey | MD | View Profile | ||
| Timothy | Johnson | MD | View Profile | ||
| Heath | Mackley | MD, FACRO | View Profile | ||
| Rogerio | Neves | MD, PhD | View Profile | ||
| Colette R. | Pameijer | MD | View Profile | ||
| Cristina | Truica | MD | View Profile | ||
| Nicholas | Zaorsky | MD | View Profile |
Research into sarcoma at Penn State Cancer Institute is conducted by a dedicated sarcoma team. See current clinical trials and members of that team here.
Blood and Bone Marrow Sampling for Tissue Banking
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens including Rare Pediatric Tumors.
Protocol for the Enrollment on the Official COG Registry, the Childhood Cancer Research Network (CCRN)
A Children's Oncology Group Protocol for Collecting and Banking Ewing Sarcoma Specimens
Umbrella Long-term Follow-up Protocol
A COG Protocol for Collecting and Banking Osteosarcoma Specimens
Renal Tumor Classification, Biology, and Banking Study
A COG Soft Tissue Sarcoma Biology and Banking Protocol
A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating with Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864, IND# 122782) in Patients with Intermediate Risk (IR) Rhabdomyosarcoma (RMS)
The Collection of Blood, Tissue and Phenotypic Data in Patients Diagnosed with Skin Cancers and Subsequent Metastases for Inclusion in a Repository and Use in Outcome Studies
Molecular-Guided Therapy for the Treatment of Patients with Relapsed and Refractory Childhood Cancers
A Phase II Study of Pazopanib (GW786034, NSC# 737754) in Children, Adolescents and Young Adults with Refractory Solid Tumors
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib
Randomized Phase III Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
A Phase I/II, Multicenter, Open-Label, Dose Escalation Study of the Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Patients with Previously Treated Solid Tumors
The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
Phase II Study of Denosumab (NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma
Protocol for a Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation
Protocol for a Research Database for Hematopoietic Cell Transplantation, other Cellular Therapies and Marrow Toxic Injuries.
| First Name | Last Name | Title | Role | ||
|---|---|---|---|---|---|
| Joseph | Drabick | MD, FACP | View Profile | ||
| Edward | Fox | MD | View Profile | ||
| Harold | Harvey | MD | View Profile | ||
| Timothy | Johnson | MD | View Profile | ||
| Heath | Mackley | MD, FACRO | View Profile | ||
| Rogerio | Neves | MD, PhD | View Profile | ||
| Colette R. | Pameijer | MD | View Profile | ||
| Cristina | Truica | MD | View Profile | ||
| Nicholas | Zaorsky | MD | View Profile |